Acadia Pharmaceuticals buy Citigroup Inc.
Start price
13.12.23
/
50%
€20.00
Target price
13.12.24
€35.17
Performance (%)
-30.68%
Price
07.08.24
€13.87
Summary
This prediction is currently active. The BUY prediction by Citigroup_Inc_ for Acadia Pharmaceuticals is performing very badly with a performance of -30.68%. This prediction currently runs until 13.12.24. The prediction end date can be changed by Citigroup_Inc_ at any time. Citigroup_Inc_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Acadia Pharmaceuticals | -19.483% | -19.483% |
| iShares Core DAX® | -5.630% | -5.765% |
| iShares Nasdaq 100 | -8.559% | -13.005% |
| iShares Nikkei 225® | -9.576% | -9.058% |
| iShares S&P 500 | -6.631% | -7.103% |
Comments by Citigroup_Inc_ for this prediction
In the thread Acadia Pharmaceuticals diskutieren
ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD) is now covered by analysts at Citigroup Inc.. They set a "buy" rating and a $38.00 price target on the stock.
Ratings data for ACAD provided by MarketBeat
Stopped prediction by Citigroup_Inc_ for Acadia Pharmaceuticals
Acadia Pharmaceuticals
Start price
Target price
Perf. (%)
€14.59
09.05.24
09.05.24
€27.83
09.05.25
09.05.25
-4.97%
07.08.24
07.08.24
